Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANUPAMA KAUL

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1710938097
CMS profile
350932
Location
HOT SPRINGS, AR

General Payments · PY2018–2024

$6,128.35

  • Reported across 301 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$699.19

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $699.19 36

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,732.68 61
PY2019 $902.37 54
PY2020 $666.58 43
PY2021 $787.18 42
PY2022 $492.30 25
PY2023 $848.05 40
PY2024 $699.19 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $27.40 02/27/2024 Food and Beverage Undisputed 01/23/2026 1078864331 CMS
Actelion Pharmaceuticals US, Inc. $27.40 07/01/2024 Food and Beverage Undisputed 01/23/2026 1078864323 CMS
Actelion Pharmaceuticals US, Inc. $26.00 08/15/2024 Food and Beverage Undisputed 01/23/2026 1078864325 CMS
AstraZeneca Pharmaceuticals LP $19.81 04/23/2024 Food and Beverage Undisputed 01/23/2026 1104210623 CMS
AstraZeneca Pharmaceuticals LP $17.65 09/10/2024 Food and Beverage Undisputed 01/23/2026 1104567266 CMS
AstraZeneca Pharmaceuticals LP $18.23 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105445612 CMS
Axsome Therapeutics, Inc. $18.27 12/19/2024 Food and Beverage Undisputed 01/23/2026 1148265309 CMS
Baxter Healthcare $13.60 02/13/2024 Food and Beverage Undisputed 01/23/2026 1118286509 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.57 03/25/2024 Food and Beverage Undisputed 01/23/2026 1118124977 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.79 11/18/2024 Food and Beverage Undisputed 01/23/2026 1118124975 CMS
Fisher & Paykel Healthcare Inc $15.68 05/06/2024 Food and Beverage Undisputed 01/23/2026 1143834977 CMS
GENZYME CORPORATION $15.23 05/07/2024 Food and Beverage Undisputed 01/23/2026 1139686833 CMS
GENZYME CORPORATION $24.35 07/18/2024 Food and Beverage Undisputed 01/23/2026 1139686895 CMS
GENZYME CORPORATION $21.94 10/21/2024 Food and Beverage Undisputed 01/23/2026 1139686923 CMS
GlaxoSmithKline, LLC. $17.97 01/29/2024 Food and Beverage Undisputed 01/23/2026 1116318268 CMS
GlaxoSmithKline, LLC. $12.03 02/01/2024 Food and Beverage Undisputed 01/23/2026 1116233174 CMS
GlaxoSmithKline, LLC. $11.16 02/12/2024 Food and Beverage Undisputed 01/23/2026 1116603706 CMS
GlaxoSmithKline, LLC. $1.50 04/03/2024 Food and Beverage Undisputed 01/23/2026 1116245040 CMS
GlaxoSmithKline, LLC. $16.32 05/08/2024 Food and Beverage Undisputed 01/23/2026 1116052540 CMS
GlaxoSmithKline, LLC. $3.62 05/21/2024 Food and Beverage Undisputed 01/23/2026 1116397188 CMS
GlaxoSmithKline, LLC. $18.31 06/03/2024 Food and Beverage Undisputed 01/23/2026 1116508177 CMS
GlaxoSmithKline, LLC. $26.24 08/01/2024 Food and Beverage Undisputed 01/23/2026 1115725702 CMS
GlaxoSmithKline, LLC. $25.12 09/26/2024 Food and Beverage Undisputed 01/23/2026 1116467062 CMS
GlaxoSmithKline, LLC. $15.62 10/24/2024 Food and Beverage Undisputed 01/23/2026 1116318164 CMS
GlaxoSmithKline, LLC. $17.86 11/21/2024 Food and Beverage Undisputed 01/23/2026 1116580827 CMS
Grifols USA, LLC $16.34 05/24/2024 Food and Beverage Undisputed 01/23/2026 1124739717 CMS
Grifols USA, LLC $18.21 07/02/2024 Food and Beverage Undisputed 01/23/2026 1124739715 CMS
HARMONY BIOSCIENCES LLC $17.93 01/02/2024 Food and Beverage Undisputed 01/23/2026 1126055996 CMS
Insmed, Inc. $19.44 10/10/2024 Food and Beverage Undisputed 01/23/2026 1089565283 CMS
Insmed, Inc. $21.66 12/16/2024 Food and Beverage Undisputed 01/23/2026 1089569584 CMS
Inspire Medical Systems, Inc. $35.59 10/03/2024 Food and Beverage Undisputed 01/23/2026 1148065915 CMS
Mylan Specialty L.P. $23.28 12/04/2024 Food and Beverage Undisputed 01/23/2026 1147362448 CMS
Regeneron Healthcare Solutions, Inc. $22.62 04/11/2024 Food and Beverage Undisputed 01/23/2026 1114083388 CMS
Regeneron Healthcare Solutions, Inc. $22.89 09/13/2024 Food and Beverage Undisputed 01/23/2026 1114083390 CMS
United Therapeutics Corporation $26.14 12/02/2024 Food and Beverage Undisputed 01/23/2026 1149458896 CMS
ZOLL Respicardia, Inc. $27.42 02/28/2024 Food and Beverage Undisputed 01/23/2026 1146935811 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.